Morphic’s stock rocketed Monday, after the biopharmaceutical company announced an agreement to be acquired by Eli Lilly in a cash deal valued at about $3.2 billion.
Oil futures moved lower early Monday, slipping after Hamas over the weekend gave its initial approval of a U.S.-backed proposal for a phased cease-fire deal with Israel in Gaza.